A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicityLutz Müller, Larry P. Yotti, Christopher M. Riley et al.|Regulatory Toxicology and Pharmacology|2006Cited by 461
Design and Synthesis of Novel Aminoindazole-pyrrolo[2,3-b]pyridine Inhibitors of IKKα That Selectively Perturb Cellular Non-Canonical NF-κB SignallingChristopher M. Riley, Simon P. Mackay|Molecules|2024Cited by 12